BRPI0606619A2 - método de análise de oligossacarìdeos, a partir do plasma sangüìneo - Google Patents
método de análise de oligossacarìdeos, a partir do plasma sangüìneoInfo
- Publication number
- BRPI0606619A2 BRPI0606619A2 BRPI0606619-4A BRPI0606619A BRPI0606619A2 BR PI0606619 A2 BRPI0606619 A2 BR PI0606619A2 BR PI0606619 A BRPI0606619 A BR PI0606619A BR PI0606619 A2 BRPI0606619 A2 BR PI0606619A2
- Authority
- BR
- Brazil
- Prior art keywords
- analysis
- blood plasma
- oligosaccharides
- molecular weight
- low molecular
- Prior art date
Links
- 238000004458 analytical method Methods 0.000 title abstract 3
- 210000002381 plasma Anatomy 0.000 title abstract 3
- 229920001542 oligosaccharide Polymers 0.000 title abstract 2
- 150000002482 oligosaccharides Chemical class 0.000 title abstract 2
- 229940127215 low-molecular weight heparin Drugs 0.000 abstract 2
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N2030/022—Column chromatography characterised by the kind of separation mechanism
- G01N2030/027—Liquid chromatography
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
- G01N2030/8809—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
- G01N2030/8813—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
- G01N2030/8809—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
- G01N2030/8813—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials
- G01N2030/8822—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials involving blood
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
- G01N2030/8809—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
- G01N2030/8813—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials
- G01N2030/8836—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials involving saccharides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
- Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
- Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
- Y10T436/143333—Saccharide [e.g., DNA, etc.]
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
MéTODO DE ANáLISE DE OLIGOSSACARìDEOS, A PARTIR DO PLASMA SANGüìNEO. A presente invenção refere-se a um método de análise dos oligossacarídeos, que constituem as heparinas de baixo peso molecular e as heparinas de peso molecular muito baixo, a partir do plasma sanguíneo.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0500554A FR2880951B1 (fr) | 2005-01-19 | 2005-01-19 | Methode d'analyse d'oligosaccharides a partir de plasma sanguin |
| PCT/FR2006/000112 WO2006077317A1 (fr) | 2005-01-19 | 2006-01-18 | Methode d'analyse d'oligosaccharides a partir de plasma sanguin |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BRPI0606619A2 true BRPI0606619A2 (pt) | 2009-07-07 |
| BRPI0606619B1 BRPI0606619B1 (pt) | 2016-12-13 |
Family
ID=35385848
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0606619A BRPI0606619B1 (pt) | 2005-01-19 | 2006-01-18 | método de análise de oligossacarídeos, a partir do plasma sangüíneo |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US7575930B2 (pt) |
| EP (1) | EP1842070B1 (pt) |
| JP (1) | JP5203714B2 (pt) |
| KR (1) | KR20070103387A (pt) |
| CN (1) | CN101107526B (pt) |
| AR (1) | AR051905A1 (pt) |
| AU (1) | AU2006207440B2 (pt) |
| BR (1) | BRPI0606619B1 (pt) |
| CA (1) | CA2591631A1 (pt) |
| FR (1) | FR2880951B1 (pt) |
| IL (1) | IL184417A (pt) |
| MX (1) | MX2007008791A (pt) |
| RU (1) | RU2415436C2 (pt) |
| WO (1) | WO2006077317A1 (pt) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1518120A4 (en) | 2002-03-11 | 2008-08-13 | Momenta Pharmaceuticals Inc | ANALYSIS OF SULFATE POLYSACCHARIDES |
| US7968082B1 (en) | 2007-01-26 | 2011-06-28 | Momenta Pharmaceuticals, Inc. | Evaluating mixtures of low molecular weight heparins by NMR |
| US7790466B1 (en) | 2007-01-26 | 2010-09-07 | Momenta Pharmaceuticals, Inc. | Evaluating mixtures of low molecular weight heparins by chain profiles or chain mapping |
| US9139876B1 (en) | 2007-05-03 | 2015-09-22 | Momenta Pharmacueticals, Inc. | Method of analyzing a preparation of a low molecular weight heparin |
| EP2256138A1 (en) * | 2009-05-05 | 2010-12-01 | Sanofi-Aventis | Novel acylated 1,6-anhhydro decasaccharide and its use as antithrombotic agent |
| ES2817779T3 (es) * | 2010-01-19 | 2021-04-08 | Momenta Pharmaceuticals Inc | Evaluación de preparaciones de heparina |
| US9068957B2 (en) | 2011-02-21 | 2015-06-30 | Momenta Pharmaceuticals, Inc. | Evaluating heparin preparations |
| WO2020252677A1 (zh) * | 2019-06-19 | 2020-12-24 | 北京三元食品股份有限公司 | 乳中游离低聚糖的高通量定量测定方法 |
| CN115112799B (zh) * | 2022-06-30 | 2023-02-28 | 北京三元食品股份有限公司 | 一种定性检测母乳中酸性低聚糖的方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE8702254D0 (sv) * | 1987-05-29 | 1987-05-29 | Kabivitrum Ab | Novel heparin derivatives |
| JPH02227144A (ja) * | 1989-02-28 | 1990-09-10 | Asahi Chem Ind Co Ltd | 陰イオン交換体及びそれを充填した糖類分離用液体クロマトグラフィー用カラム |
| US5843786A (en) * | 1995-11-28 | 1998-12-01 | Neose Technologies, Inc. | Analysis of carbohydrates in biological fluids by high performance liquid chromatography |
| US6291439B1 (en) * | 1998-09-02 | 2001-09-18 | Biomarin Pharmaceuticals | Methods for diagnosing atherosclerosis by measuring endogenous heparin and methods for treating atherosclerosis using heparin |
| US6617316B1 (en) * | 1999-10-22 | 2003-09-09 | Aventis Pharma | Oligosaccharides, their preparation and pharmaceutical compositions containing them |
| EP1518120A4 (en) * | 2002-03-11 | 2008-08-13 | Momenta Pharmaceuticals Inc | ANALYSIS OF SULFATE POLYSACCHARIDES |
| CA2499537A1 (fr) * | 2002-09-23 | 2004-04-01 | Aventis Pharma S.A. | Methode de determination de groupements specifiques constituant les heparines ou les heparines de bas poids moleculaire |
| FR2844808B1 (fr) * | 2002-09-23 | 2005-02-25 | Aventis Pharma Sa | Methode de determination de groupements specifiques constituant les heparines ou les heparines de bas poids moleculaire |
| US20040265943A1 (en) * | 2002-09-23 | 2004-12-30 | Aventis Pharma S.A. | Method for quantitatively determining specific groups constituting heparins or low molecular weight heparins |
-
2005
- 2005-01-19 FR FR0500554A patent/FR2880951B1/fr not_active Expired - Fee Related
-
2006
- 2006-01-18 AU AU2006207440A patent/AU2006207440B2/en not_active Ceased
- 2006-01-18 MX MX2007008791A patent/MX2007008791A/es active IP Right Grant
- 2006-01-18 CA CA002591631A patent/CA2591631A1/fr not_active Abandoned
- 2006-01-18 EP EP06709119.9A patent/EP1842070B1/fr not_active Expired - Lifetime
- 2006-01-18 CN CN2006800025553A patent/CN101107526B/zh not_active Expired - Lifetime
- 2006-01-18 BR BRPI0606619A patent/BRPI0606619B1/pt not_active IP Right Cessation
- 2006-01-18 AR ARP060100190A patent/AR051905A1/es active IP Right Grant
- 2006-01-18 RU RU2007131442/15A patent/RU2415436C2/ru not_active IP Right Cessation
- 2006-01-18 WO PCT/FR2006/000112 patent/WO2006077317A1/fr not_active Ceased
- 2006-01-18 KR KR1020077016393A patent/KR20070103387A/ko not_active Ceased
- 2006-01-18 JP JP2007551702A patent/JP5203714B2/ja not_active Expired - Fee Related
-
2007
- 2007-07-04 IL IL184417A patent/IL184417A/en not_active IP Right Cessation
- 2007-07-13 US US11/777,431 patent/US7575930B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0606619B1 (pt) | 2016-12-13 |
| RU2415436C2 (ru) | 2011-03-27 |
| IL184417A0 (en) | 2007-10-31 |
| RU2007131442A (ru) | 2009-02-27 |
| AU2006207440B2 (en) | 2011-04-21 |
| US7575930B2 (en) | 2009-08-18 |
| JP5203714B2 (ja) | 2013-06-05 |
| AU2006207440A1 (en) | 2006-07-27 |
| KR20070103387A (ko) | 2007-10-23 |
| CA2591631A1 (fr) | 2006-07-27 |
| JP2008527390A (ja) | 2008-07-24 |
| EP1842070A1 (fr) | 2007-10-10 |
| CN101107526B (zh) | 2013-08-14 |
| IL184417A (en) | 2011-10-31 |
| FR2880951B1 (fr) | 2015-09-18 |
| US20080009069A1 (en) | 2008-01-10 |
| FR2880951A1 (fr) | 2006-07-21 |
| AR051905A1 (es) | 2007-02-14 |
| WO2006077317A1 (fr) | 2006-07-27 |
| CN101107526A (zh) | 2008-01-16 |
| EP1842070B1 (fr) | 2016-04-13 |
| MX2007008791A (es) | 2007-09-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE427965T1 (de) | Antikírper gegen 25-hydroxyvitamin d | |
| CY1112781T1 (el) | 2'-φθορο-2'-δεοξυτετραϋδροουριδινες ως αναστολεις αποαμινασης κυτιδινης | |
| BRPI0717822A2 (pt) | Composto, processo de fabricação de composto da fórmula i, composição farmacêutica, método de tratamento e/ou profilaxia de doenças que são associadas à modulação de receptores de cb2 e uso de composto. | |
| DE602006010564D1 (de) | Pyridoä2,3-düpyrimidin-2,4-diamin-verbindungen als ptpib-hemmer | |
| MA32934B1 (fr) | Combinaisons inhibitrices hsp90 | |
| EP2041274A4 (en) | PREPARATION OF A SHORT-COATED VOLATILE HYDROCARBON BASED ON GENERALLY MANIPULATED MICROALGEN, CYANOBACTERIA OR BACTERIA | |
| EA200970580A1 (ru) | Таннат разагилина | |
| BRPI0818374A8 (pt) | Substratos porosos hidrofílicos | |
| EP2033324A4 (en) | MEMBRANES, COATINGS AND FILMS AND MANUFACTURING METHOD THEREFOR | |
| EA201170227A1 (ru) | Имидазолкарбоксамиды | |
| BRPI0720153A8 (pt) | Composições e artigos que contêm uma matriz de polímero reticulada e um líquido ativo imobilizado assim como processos de utilização dos mesmos | |
| EP2061808A4 (en) | INFLUENZA ANTIBODIES, COMPOSITIONS AND RELATED METHODS | |
| ECSP109968A (es) | Depsipéptidos cíclicos | |
| BRPI0713031B8 (pt) | composto de di-hidro-piran-2-ona, composição farmacêutica, e uso dos mesmos | |
| BRPI0811933A2 (pt) | Avaliação da proporção de gás-óleo sa partir de outras propriedades físicas | |
| BRPI1015043A2 (pt) | derivados de diazahomoadamantano e métodos de uso dos mesmos | |
| EP2238451A4 (en) | NANOSTRUCTURES, METHOD FOR THE PRODUCTION THEREOF AND USES THEREOF | |
| BR112012014060A2 (pt) | métodos e reagentes para detecção aprimorada de peptídeos beta-amiloides | |
| CO6241120A2 (es) | (DIHIDRO)PIRROLO[2,1-á]ISOQUINOLINAS. | |
| EP2366691A4 (en) | NITROPYRIDINYLETHYLENIMINE COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING THEREOF, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE | |
| CL2007003593A1 (es) | Composicion farmaceutica que comprende fluoresceina pura; procedimiento de preparacion de la fluoresceina. | |
| ATE524076T1 (de) | Niedrig-glykämische mischungen | |
| BRPI0818409B8 (pt) | Método de identificação de uma planta de milho ou germoplasma que apresenta resistência recém-conferida ou resistência aumentada a um membro do sorogrupo 2 de fijivirus, ou suscetibilidade a um membro do sorogrupo 2 de fijivírus, método de produção de uma planta de milho apresentando resistência recém-conferida ou resistência aumentada a um membro do sorogrupo 2 de fijivírus e método de seleção de pelo menos uma planta de milho através de seleção assistida por marcador de um lócus de traço quantitativo associado com a resistência recém-conferida ou resistência aumentada a um membro do sorogrupo 2 de fijivírus | |
| MX2011006516A (es) | Terapia de combinacion de virus de hepatitis c. | |
| WO2007035872A3 (en) | Tdf-related compounds and analogs thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B06H | Technical and formal requirements: requirement cancelled [chapter 6.8 patent gazette] |
Free format text: REF. A RPI NO 2150 DE 20/03/2012. ANULACAO DA EXIGENCIA 6.6 POR TER SIDO INDEVIDA. REQUERENTE NAO APRESENTOU RESPOSTA A EXIGENCIA CONFORME DISPOE A RESOLUCAO 207 DE 24/04/2009, ENTRETANTO, A RESPOSTA CONSTA NO FORMULARIO DE DEPOSITO. |
|
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 13/12/2016, OBSERVADAS AS CONDICOES LEGAIS. |
|
| B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE A 15A ANUIDADE. |
|
| B24J | Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12) |
Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2614 DE 09-02-2021 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |